HOME >> MEDICINE >> NEWS
Mayo Clinic: New recommendations for use of bisphosphonates in treatment of multiple myeloma

ROCHESTER, Minn. -- Mayo Clinic's multiple myeloma (MM) research team has jointly issued a consensus statement regarding the use of bisphosphonates to prevent or treat bone disease in MM. Their recommendations address several controversial issues, including the type of bisphosphonate to be used and the duration of such therapy, and are available in the August issue of Mayo Clinic Proceedings.

"It was imperative that we address the issue that has been under recent intense debate due to patient safety concerns," said Martha Lacy, M.D., Mayo Clinic hematologist and lead author of the statement. "These drugs have far-ranging effects that raised concerns in the medical field, so we brought together the relevant specialists to develop a set of best practice recommendations. We published them in Mayo Clinic Proceedings in order to provide other physicians the benefit of our shared knowledge."

The Mayo Clinic team provided recommendations for the myeloma patients for whom bisphosphonates are indicated. They said pamidronate should be the bisphosphonate of choice for patients who are starting therapy, over the newer, more potent drug zoledronic acid, which is more frequently associated with serious damage to jaw bones. Also in the interest of safety, the team recommended that patients without active disease stop bisphosphonate therapy after two years, and patients with active disease reduce the frequency at which the drugs are given.

MM is a malignant plasma cell disorder that is diagnosed in more than 15,000 people each year in the United States, and which causes more than 11,000 deaths. There are a variety of treatment options for MM, but it remains an incurable disease with current emphasis placed on enhancing quality of life while the cure is sought.

Because bone destruction causes significant problems for MM patients, and painful results include osteoporosis, lytic bone disease and skeletal fractures, clinicians seek t
'"/>


10-Aug-2006


Page: 1 2

Related medicine news :

1. Mayo Clinic: Sinusitis is common yet often overlooked cause of chronic cough
2. Mayo Clinic: Biomarker that may improve quality of life during treatment for colorectal cancer
3. Article outlines current recommendations for treating malaria in the US
4. Drug safety recommendations lack scientific evidence
5. SCAI issues recommendations to prevent kidney damage after imaging procedures
6. New recommendations for the diagnosis of Pulmonary Embolism
7. Latest influenza science and recommendations presented in new release
8. Heart Rhythm Society publishes final recommendations for heart patients
9. UK recommendations on the availability of common painkillers are being contravened
10. NIDA announces recommendations to treat drug abusers, save money and reduce crime
11. Concern over aggressive cholesterol recommendations

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... Pullano Law Offices, a ... L. Pullano has been selected to serve as President of the North Suburban ... the Installation and Award Dinner hosted by the NSBA at the North Shore Country ...
(Date:9/22/2017)... ... September 22, 2017 , ... TopConsumerReviews.com recently awarded ... Remedies that helps promote pancreatic health and regulate blood sugar levels . ... approaches can have negative side effects, and with the changes in today’s healthcare ...
(Date:9/22/2017)... ... 22, 2017 , ... "Success Files," a short- and long-form ... is a disease estimated to affect the lives of more than 5 million ... Association, a leading voice in the fight for cure and research into the ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Fruit of the Spirit: “Love””: ... exploring nature that God has created. “Fruit of the Spirit: “Love”” is the creation ... a devoted wife and mother of five. Halimah is an avid writer, her inspiration ...
(Date:9/22/2017)... ... 22, 2017 , ... The freshly released app Smart Mart ... Smart Mart, customers can now order vegetable, fruit, snacks, dairy, or any eatables. ... clothing at discounted prices. Apart from this, Smart Mart has emphasized upon their ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... PDI , a leader in infection prevention products and ... focused on the role of chlorhexidine gluconate (CHG) in ... Annual Scientific Meeting of the Association for Vascular Access. ... Phoenix Convention Center in ... feature PDI,s Prevantics® Device Swab as the ...
(Date:9/5/2017)... NEWTOWN, Pa. , Sept. 5, 2017  Xyntek Inc. has announced another ... opened a new Midwest office to meet the growing demands of customer engagements ... Xyntek's new Midwest office is located at ... ... demands of customer engagements regionally. ...
(Date:9/1/2017)... , Sept. 1, 2017 Michael Penna ... Inc , highlights opportunities for growth in his response ... that Marlin Equity is seeking a buyer for eMDs. ... award-winning 22-year-old healthcare solutions Value Added Reseller and national ... "As the healthcare market continues ...
Breaking Medicine Technology:
Cached News: